BLTE

Belite Bio
BLTE

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.19B
EV
$2.04B
Shares Outstanding
36.68M
Beta
-1.50

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$93.75
P/E 2025E
-
P/Revenue 2025E
198.86x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Belite Bio, Inc

gainify
BLTE

Belite Bio, Inc

BLTE

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company’s lead product candidate ...

Sector

Healthcare

Industry

Biotechnology

CEO

Lin, Yu-Hsin

Employees

25

IPO Date

2022-04-29

Headquarters

12750 High Bluff Drive, Suite 475, San Diego, California, 92130, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.